COBENFY Trademark

Trademark Overview

On Monday, March 28, 2022, a trademark application was filed for COBENFY with the United States Patent and Trademark Office. The USPTO has given the COBENFY trademark a serial number of 97333525. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, June 27, 2024. This trademark is owned by Karuna Therapeutics, Inc.. The COBENFY trademark is filed in the Pharmaceutical Products category with the following description:

prescription medications for the treatment of neuropsychiatric disorders
cobenfy

General Information

Serial Number97333525
Word MarkCOBENFY
Filing DateMonday, March 28, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, June 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements

Goods and Servicesprescription medications for the treatment of neuropsychiatric disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKaruna Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameKaruna Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Friday, April 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 31, 2022NEW APPLICATION ENTERED
Tuesday, May 24, 2022ASSIGNED TO EXAMINER
Tuesday, May 24, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 24, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 29, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 29, 2023SOU EXTENSION 1 FILED
Thursday, June 29, 2023SOU EXTENSION 1 GRANTED
Saturday, July 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU EXTENSION 3 FILED
Thursday, June 27, 2024SOU EXTENSION 3 GRANTED
Tuesday, September 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 2, 2024SOU EXTENSION 2 FILED
Tuesday, January 2, 2024SOU EXTENSION 2 GRANTED
Thursday, January 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 9, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 9, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 9, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 10, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, September 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

cobenfy disorders neuropsychiatric treatment medications prescription